# vTv Therapeutics Inc. (VTVT) stock: price and valuation

URL: https://funkfolio.com/stock/VTVT

> vTv Therapeutics Inc. (VTVT) trades at $17.29 and is worth $69.36M. Valuation against its own history and up to 20 years of financials.

---

## vTv Therapeutics Inc. (VTVT)

vTv Therapeutics Inc. (VTVT) is a healthcare company (biotechnology) based in the United States. The share price is $17.29, down 2.26% on the day, which values the company at $69.36M. Price as of 18 Nov 2026, 00:15 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $17.29 −2.26% today
- **Market value:** $69.36M
- **200-week average:** $23.40 26% below
- **Sector:** Healthcare

Figures as of 18 Nov 2026, 00:15 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### vTv Therapeutics Inc. in more detail

VTVT trades at -4.5× next year's expected earnings, 1.9× sales. It sits 26% below its 200-week average of $23.40.

Worth checking: Share count keeps rising; Thin interest cover.

1 of the superinvestors tracked here hold VTVT, including Julian and Felix Baker (0.0% of the portfolio).

### Superinvestors holding VTVT

1 of the investors tracked here report a position in their latest 13F filing.

- [Julian and Felix Baker Baker Bros. Advisors](https://funkfolio.com/gurus/baker-brothers) 0.03% of portfolio · $5.6M · Q2 2026

### vTv Therapeutics Inc. (VTVT): questions and answers

**What is vTv Therapeutics Inc.'s market cap?**

vTv Therapeutics Inc. is valued at $69.36M at a share price of $17.29.

**Is VTVT above its 200-week moving average?**

No. VTVT is 26.1% below its 200-week average of $23.40. Long-term investors watch that line because strong companies rarely trade below it for long.

**Does VTVT pay a dividend?**

vTv Therapeutics Inc. does not currently pay a regular dividend.

**Which famous investors own VTVT?**

In their latest quarterly filings, Julian and Felix Baker (0.0% of the portfolio) hold VTVT. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “vTv Therapeutics Inc. (VTVT) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/VTVT

Underlying data: Yahoo Finance; company filings with the SEC.
